For the latest COVID-19 campus news and resources, visit

Search Close Search


Kristina Deligiannidis talks to WBZ-TV about new international peripartum depression study

By Sarah Willey

UMass Medical School Communications

May 17, 2016
  Ashley Poniros, a patient of Dr. Deligiannidis, is participating in the study. Poniros suffered from depression during her pregnancy for her third son.

Ashley Poniros, a patient of Dr. Deligiannidis, was interviewed by Dr. Mallika Marshall about the study. 

UMass Medical School neuroscientist Kristina Deligiannidis, MD, talked with Dr. Mallika Marshall of WBZ-TV for a health segment about a new international study aimed at determining whether a woman’s DNA impacts her risk for peripartum depression, a condition that affects one in eight women.

UMMS is one of 20 sites in the United States participating in the international Postpartum Depression: Action Toward Causes and Treatment (PACT) research initiative. It’s the largest-ever study that will compare genetic profiles of women with and without postpartum depression.

As part of the study, women sign up using an app in which they answer a short questionnaire, and offer a saliva sample to help identify genetic differences in women who have PPD.

Dr. Deligiannidis, associate professor of psychiatry and obstetrics & gynecology, explained the long-term goal of the study and the potential benefits.

“Can we get a better sense of who’s at risk? Because ideally we want to intervene earlier, before a woman develops the disease.” Deligiannidis said.

To watch the full segment, visit: